Auto - Parts
Build Your Comparison
Side-by-side financial analysisStock Comparison
CREVW vs CREV vs THRM vs JPM vs MPAA
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
Auto - Parts
Banks - Diversified
Auto - Parts
CREVW vs CREV vs THRM vs JPM vs MPAA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Parts | Auto - Parts | Auto - Parts | Banks - Diversified | Auto - Parts |
| Market Cap | — | $775K | $1.10B | $908.57B | $291M |
| Revenue (TTM) | $58M | $58M | $1.53B | $280.33B | $790M |
| Net Income (TTM) | $-46M | $-46M | $23M | $57.05B | $12M |
| Gross Margin | -40.2% | -40.2% | 23.6% | 60.0% | 20.2% |
| Operating Margin | -63.3% | -63.3% | 4.7% | 25.9% | 6.5% |
| Forward P/E | — | — | 13.3x | 14.6x | 20.5x |
| Total Debt | $111M | $111M | $295M | $942.38B | $200M |
| Cash & Equiv. | $4M | $4M | $161M | $343.34B | $15M |
CREVW vs CREV vs THRM vs JPM vs MPAA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 23 | Apr 26 | Return |
|---|---|---|---|
| Carbon Revolution P… (CREVW) | 100 | 6.3 | -93.8% |
| Carbon Revolution P… (CREV) | 100 | 1.2 | -98.8% |
| Gentherm Incorporat… (THRM) | 100 | 77.7 | -22.3% |
| JPMorgan Chase & Co. (JPM) | 100 | 200.6 | +100.6% |
| Motorcar Parts of A… (MPAA) | 100 | 136.7 | +36.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CREVW vs CREV vs THRM vs JPM vs MPAA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CREVW ranks third and is worth considering specifically for growth exposure.
- Rev growth 86.8%, EPS growth 100.0%, 3Y rev CAGR 26.9%
- 86.8% revenue growth vs THRM's 2.6%
Among these 5 stocks, CREV doesn't own a clear edge in any measured category.
THRM is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 1.43, Low D/E 40.9%, current ratio 1.92x
- Lower P/E (13.3x vs 20.5x)
- 1.6% ROA vs CREV's -27.5%, ROIC 7.3% vs -27.1%
JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.87, yield 1.8%
- 481.2% 10Y total return vs THRM's -4.2%
- 20.4% margin vs CREV's -79.6%
- Beta 0.87 vs CREV's 2.02
MPAA is the clearest fit if your priority is defensive.
- Beta 0.87, current ratio 1.46x
- +55.0% vs CREV's -81.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 86.8% revenue growth vs THRM's 2.6% | |
| Value | Lower P/E (13.3x vs 20.5x) | |
| Quality / Margins | 20.4% margin vs CREV's -79.6% | |
| Stability / Safety | Beta 0.87 vs CREV's 2.02 | |
| Dividends | 1.8% yield; 15-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +55.0% vs CREV's -81.7% | |
| Efficiency (ROA) | 1.6% ROA vs CREV's -27.5%, ROIC 7.3% vs -27.1% |
CREVW vs CREV vs THRM vs JPM vs MPAA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CREVW vs CREV vs THRM vs JPM vs MPAA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
THRM leads 1 • MPAA leads 1 • CREVW leads 0 • CREV leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4864.7x CREV's $58M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CREV's -79.6%. On growth, CREVW holds the edge at +107.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $58M | $58M | $1.5B | $280.3B | $790M |
| EBITDAEarnings before interest/tax | -$25M | -$25M | $127M | $81.4B | $59M |
| Net IncomeAfter-tax profit | -$46M | -$46M | $23M | $57.0B | $12M |
| Free Cash FlowCash after capex | -$62M | -$62M | $79M | $100.9B | $1M |
| Gross MarginGross profit ÷ Revenue | -40.2% | -40.2% | +23.6% | +60.0% | +20.2% |
| Operating MarginEBIT ÷ Revenue | -63.3% | -63.3% | +4.7% | +25.9% | +6.5% |
| Net MarginNet income ÷ Revenue | -79.6% | -79.6% | +1.5% | +20.4% | +1.6% |
| FCF MarginFCF ÷ Revenue | -107.6% | -107.6% | +5.1% | +36.0% | +0.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +107.9% | +107.9% | +11.3% | — | +9.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -156.9% | -156.9% | — | +16.0% | +12.4% |
Valuation Metrics
Evenly matched — JPM and MPAA each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 16.2x trailing earnings, JPM trades at a 73% valuation discount to THRM's 59.9x P/E. On an enterprise value basis, MPAA's 7.2x EV/EBITDA is more attractive than JPM's 18.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | — | $775,174 | $1.1B | $908.6B | $291M |
| Enterprise ValueMkt cap + debt − cash | — | $78M | $1.2B | $1.51T | $476M |
| Trailing P/EPrice ÷ TTM EPS | — | — | 59.88x | 16.22x | 24.77x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 13.26x | 14.60x | 20.48x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.92x | — |
| EV / EBITDAEnterprise value multiple | — | — | 9.41x | 18.52x | 7.23x |
| Price / SalesMarket cap ÷ Revenue | — | 0.02x | 0.74x | 3.25x | 0.37x |
| Price / BookPrice ÷ Book value/share | — | — | 1.54x | 2.51x | 1.15x |
| Price / FCFMarket cap ÷ FCF | — | — | 18.02x | 9.01x | 78.65x |
Profitability & Efficiency
THRM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-21 for CREV. THRM carries lower financial leverage with a 0.41x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), THRM scores 5/9 vs CREV's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -21.2% | -21.2% | +3.2% | +15.9% | +4.8% |
| ROA (TTM)Return on assets | -27.5% | -27.5% | +1.6% | +1.3% | +1.2% |
| ROICReturn on invested capital | -27.1% | -27.1% | +7.3% | +4.5% | +11.0% |
| ROCEReturn on capital employed | -3.1% | -3.1% | +8.2% | +8.9% | +10.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 5 | 4 |
| Debt / EquityFinancial leverage | — | — | 0.41x | 2.60x | 0.75x |
| Net DebtTotal debt minus cash | $107M | $107M | $134M | $599.0B | $185M |
| Cash & Equiv.Liquid assets | $4M | $4M | $161M | $343.3B | $15M |
| Total DebtShort + long-term debt | $111M | $111M | $295M | $942.4B | $200M |
| Interest CoverageEBIT ÷ Interest expense | -7.47x | -7.47x | 5.83x | 0.74x | 0.86x |
Total Returns (Dividends Reinvested)
MPAA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $137 for CREV. Over the past 12 months, MPAA leads with a +55.0% total return vs CREV's -81.7%. The 3-year compound annual growth rate (CAGR) favors MPAA at 33.7% vs CREV's -76.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -51.4% | -76.8% | -2.4% | +0.8% | +24.3% |
| 1-Year ReturnPast 12 months | -79.7% | -81.7% | +30.9% | +20.9% | +55.0% |
| 3-Year ReturnCumulative with dividends | — | -98.6% | -36.9% | +138.8% | +139.3% |
| 5-Year ReturnCumulative with dividends | — | -98.6% | -47.1% | +135.5% | -31.0% |
| 10-Year ReturnCumulative with dividends | — | -98.6% | -4.2% | +481.2% | -50.5% |
| CAGR (3Y)Annualised 3-year return | — | -76.1% | -14.2% | +33.7% | +33.7% |
Risk & Volatility
Evenly matched — CREVW and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
CREVW is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than CREV's 2.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs CREV's 4.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.20x | 2.02x | 1.43x | 0.87x | 0.87x |
| 52-Week HighHighest price in past year | $0.05 | $9.20 | $39.48 | $338.09 | $18.12 |
| 52-Week LowLowest price in past year | $0.00 | $0.01 | $27.00 | $269.72 | $9.29 |
| % of 52W HighCurrent price vs 52-week peak | +6.8% | +4.4% | +91.0% | +96.2% | +84.8% |
| RSI (14)Momentum oscillator 0–100 | 34.2 | 44.2 | 58.3 | 72.1 | 69.6 |
| Avg Volume (50D)Average daily shares traded | 61K | 469K | 279K | 7.4M | 83K |
Analyst Outlook
JPM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: THRM as "Buy", JPM as "Buy", MPAA as "Buy". Consensus price targets imply 30.2% upside for MPAA (target: $20) vs 2.1% for THRM (target: $37). JPM is the only dividend payer here at 1.83% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $36.67 | $339.75 | $20.00 |
| # AnalystsCovering analysts | — | — | 15 | 61 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +1.8% | — |
| Dividend StreakConsecutive years of raises | — | — | 0 | 15 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $5.95 | — |
| Buyback YieldShare repurchases ÷ mkt cap | — | 0.0% | +0.9% | +3.8% | 0.0% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). THRM leads in 1 (Profitability & Efficiency). 2 tied.
CREVW vs CREV vs THRM vs JPM vs MPAA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CREVW or CREV or THRM or JPM or MPAA a better buy right now?
For growth investors, Carbon Revolution Public Limited Company Warrant (CREVW) is the stronger pick with 86.
8% revenue growth year-over-year, versus 2. 6% for Gentherm Incorporated (THRM). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate Gentherm Incorporated (THRM) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CREVW or CREV or THRM or JPM or MPAA?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 2x versus Gentherm Incorporated at 59. 9x. On forward P/E, Gentherm Incorporated is actually cheaper at 13. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CREVW or CREV or THRM or JPM or MPAA?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +135. 5%, compared to -98. 6% for Carbon Revolution Public Limited Ordinary Shares (CREV). Over 10 years, the gap is even starker: JPM returned +481. 2% versus CREV's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CREVW or CREV or THRM or JPM or MPAA?
By beta (market sensitivity over 5 years), Carbon Revolution Public Limited Company Warrant (CREVW) is the lower-risk stock at -0.
20β versus Carbon Revolution Public Limited Ordinary Shares's 2. 02β — meaning CREV is approximately -1109% more volatile than CREVW relative to the S&P 500. On balance sheet safety, Gentherm Incorporated (THRM) carries a lower debt/equity ratio of 41% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CREVW or CREV or THRM or JPM or MPAA?
By revenue growth (latest reported year), Carbon Revolution Public Limited Company Warrant (CREVW) is pulling ahead at 86.
8% versus 2. 6% for Gentherm Incorporated (THRM). On earnings-per-share growth, the picture is similar: Motorcar Parts of America, Inc. grew EPS 162. 6% year-over-year, compared to -70. 9% for Gentherm Incorporated. Over a 3-year CAGR, CREVW leads at 26. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CREVW or CREV or THRM or JPM or MPAA?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -309. 4% for Carbon Revolution Public Limited Ordinary Shares — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -235. 9% for CREV. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CREVW or CREV or THRM or JPM or MPAA more undervalued right now?
On forward earnings alone, Gentherm Incorporated (THRM) trades at 13.
3x forward P/E versus 20. 5x for Motorcar Parts of America, Inc. — 7. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MPAA: 30. 2% to $20. 00.
08Which pays a better dividend — CREVW or CREV or THRM or JPM or MPAA?
In this comparison, JPM (1.
8% yield) pays a dividend. CREVW, CREV, THRM, MPAA do not pay a meaningful dividend and should not be held primarily for income.
09Is CREVW or CREV or THRM or JPM or MPAA better for a retirement portfolio?
For long-horizon retirement investors, Carbon Revolution Public Limited Company Warrant (CREVW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20)). Carbon Revolution Public Limited Ordinary Shares (CREV) carries a higher beta of 2. 02 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CREVW and CREV and THRM and JPM and MPAA?
These companies operate in different sectors (CREVW (Consumer Cyclical) and CREV (Consumer Cyclical) and THRM (Consumer Cyclical) and JPM (Financial Services) and MPAA (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CREVW is a small-cap high-growth stock; CREV is a small-cap high-growth stock; THRM is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; MPAA is a small-cap quality compounder stock. JPM pays a dividend while CREVW, CREV, THRM, MPAA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.